Skip to main content
Log in

Dinitrophenol and bioenergetics: An historical perspective

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Summary

The subject of the paper is the history of dinitrophenol compounds in relationship to bioenergetics. The history of the interaction between dinitrophenols and bioenergetics can be traced back to 1885 whenCazeneuve andLÉpine discovered the thermogenic effects of dinitronapthol. Dinitronapthol and dinitrocresol were used as food colors in the late 19th century although a growing awareness of their toxic properties led to the prohibition of their use for this purpose in certain countries. The toxicity of dinitrophenol was studied in some detail byMayer and his colleagues in France during World War I since it was used by the French in the manufacture of munitions. They recognized that the compound stimulated cellular metabolism, but they did not publish their results until many years later and as a result their work was at first not widely known. In the late 1920's and early 1930's, CorneilleHeymans and his colleagues at Ghent andCutting andTainter and their colleagues at Stanford demonstrated the metabolic stimulating powers of dinitronapthol and dinitrophenol. The Stanford group introduced dinitrophenol into therapeutics for the treatment of obesity, and the drug soon found its way into numerous “anti-fat” patent medicines. Several fatalities, a number of cases of cataract, and other reported toxic effects led to widespread concern about the use of dinitrophenol. The FDA could not take effective action against the drug, however, until after its powers had been expanded by the 1938 Food, Drug and Cosmetic Act. The use of dinitrophenol and related compounds for treating obesity was essentially discontinued after the 1930's. Studies on the mode of action of dinitrophenol in the 1930's and 1940's led ultimately to the establishment of the fact that it uncouples oxidative phosphorylation (Loomis andLipmann, 1948).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. P. Cazeneuve and R. Lépine, Compt. Rend. Soc. Biol. 101, 1167–1169 (1885).

    Google Scholar 

  2. T. Weyl, Die Theerfarben, pp. 53–71, Hirschwald, Berlin (1889).

    Google Scholar 

  3. W. Gibbs and E. Reichert, Amer. Chem. J. 13, 307 (1891)

    Google Scholar 

  4. W. Gibbs and E. Reichert, Amer. Chem. J. 16, 443–449 (1894).

    Google Scholar 

  5. G. Edsall, New Eng. J. Med. 211, 385–390 (1934).

    Google Scholar 

  6. E. W. Simon, Biol. Rev. 28, 453–479 (1953).

    Google Scholar 

  7. T. Weyl, op. cit., pp. 18–35.

    Google Scholar 

  8. B. Hesse, USDA Bureau of Chemistry Bulletin 147, pp. 35–40 (1912).

    Google Scholar 

  9. ibid., pp. 9–10.

    Google Scholar 

  10. A. Mathews and E. Longfellow, J. Pharmacol. Exper. Ther. 2, 201–219 (1910).

    Google Scholar 

  11. R. Perkins, Pub. Health Rep. 34, 2335–2374 (1919)

    Google Scholar 

  12. E. Quingnard, Essai Clinique sur L'Intoxication par le Dinitrophenol 1-2-4, M. D. thesis, Paris (1919).

  13. A. Hamilton, Industrial Poisons in the United States pp. 499–500, Macmillan, New York (1925).

    Google Scholar 

  14. M. Courtois-Suffit and Zedet, Hygiene Industrielle: Lutte contre les Intoxications dans la Fabrication des Poudres et Explosifs, pp. 27–36, 226–229, 232–233, 309, J. B. Baillière et Fils, Paris (1932).

  15. C. Heymans and H. Casier, Arch. Internat. Pharmacodyn. Ther. 50, 20–64 (1935).

    Google Scholar 

  16. W. C. Cutting and M. L. Tainter, Proc. Soc. Exper. Biol. Med. 29, 1268–1269 (1932).

    Google Scholar 

  17. M. L. Tainter, W. C. Cutting and A. B. Stockton, Amer. J. Pub. Health 24, 1045–1053 (1934).

    Google Scholar 

  18. M. L. Tainter and W. C. Cutting, J. Pharmacol. Exper. Ther. 48, 410–429 (1933)

    Google Scholar 

  19. H. Magne, A. Mayer and L. Plantefol, Ann. Physiol. Physiochim. Biol. 7, 269–273 (1931).

    Google Scholar 

  20. H. Magne, A. Mayer and L. Plantefol, Ann. Physiol. Physiochim. Biol. 8, 1–194 (1932).

    Google Scholar 

  21. M. L. Tainter, A. B. Stockton and W. C. Cutting, J. Amer. Med. Assoc. 101, 193–195, 1472–1475, 2099–2102 (1933).

    Google Scholar 

  22. M. L. Tainter, A. B. Stockton and W. C. Cutting, J. Amer. Med. Assoc. 105, 332–336 (1935).

    Google Scholar 

  23. E. C. Dodds and W. J. Pope, Lancet 2, 352–353 (1933).

    Google Scholar 

  24. E. C. Dodds and J. D. Robertson, Lancet 2, 1137–1139 (1933).

    Google Scholar 

  25. M. L. Tainter, F. W. Bergstrom and W. C. Cutting,. Pharmacol. Exper. Ther. 53, 58–66 (1935).

    Google Scholar 

  26. C. Heymans and H. Casier, Compt. Rend. Soc. Biol. 114, 1384–1385 (1933).

    Google Scholar 

  27. Anonymous, Newsweek 2(6), 28 (Sept. 9, 1933).

  28. W. W. Boardman, J. Amer. Med. Assoc. 105, 108 (1935).

    Google Scholar 

  29. W. Horner, R. Jones and W. W. Boardman, J. Amer. Med. Assoc. 105, 108–110 (1935).

    Google Scholar 

  30. D. M. Dunlop, Brit. Med. J. 1, 524–527 (1934).

    Google Scholar 

  31. J. Strong and F. Evans, J. Amer. Med. Assoc. 104, 1957–1963 (1935).

    Google Scholar 

  32. Editorial, J. Amer. Med. Assoc. 101, 213–214 (1933).

    Google Scholar 

  33. W. F. Christie, Obesity: A Practical Handbook for Physicians, pp. 174–176, William Heinemann, London (1937).

    Google Scholar 

  34. M. L. Tainter, F. W. Bergstrom and W. C. Cutting, J. Pharmacol. Exper. Ther. 53, 58–66 (1935).

    Google Scholar 

  35. A. J. Cramp, Hygeia 13, 50–54, 66 (1935).

    Google Scholar 

  36. R. L. Palmer and S. K. Greenberg, Facts and Frauds in Woman's Hygiene, p. 223, Vanguard Press, New York (1936).

    Google Scholar 

  37. Anonymous, Sci. Amer. 153, 273 (1935).

  38. Charles Jackson, Pharmacy in History 13, 103–110 (1971).

    Google Scholar 

  39. Palmer and Greenberg, op. cit., pp. 222–223

    Google Scholar 

  40. W. W. Bauer, Health, Hygeine and Hooey, p. 181, Boobs-Merrill, Indianapolis, (1938).

    Google Scholar 

  41. R. Lamb, American Chamber of Horrors: The Truth about Food and Drugs, pp. 94–97, Farrar and Rinehart, New York (1936).

    Google Scholar 

  42. P. Hawk, Streamline for Health, pp. 126–127, Harper, New York (1935).

    Google Scholar 

  43. J. H. Young, The Medical Messiahs: A History of Health Quackery in Twentieth-Century America, pp. 54, 120–123, Princeton University Press, Princeton, N. J. (1967).

    Google Scholar 

  44. W. Campbell, Report of the Food and Drug Administration, p. 14 (1933).

  45. USDA, Food and Drug Administration (1936) Notices of Judgement under the Food and Drug Act, no. 25850.

  46. W. Campbell, Report of the Food and Drug Administration, p. 15 (1938).

  47. W. Campbell, Report of the Food and Drug Administration, p. 5 (1939).

  48. W. Campbell, Report of the Food and Drug Administration, p. 15 (1940).

  49. E. Ronzoni and E. Ehrenfest, J. Biol. Chem. 115, 749–768 (1936)

    Google Scholar 

  50. R. H. De Meio and E. S. G. Barron, Proc. Soc. Exper. Biol. Med. 32, 36–39 (the quotation is from p. 39) (1934).

    Google Scholar 

  51. M. E. Krahl and G. H. A. Clowes, J. Biol. Chem. 111, 355–369 (1935).

    Google Scholar 

  52. B. Terada and M. L. Tainter, J. Pharmacol. Exper. Ther. 54, 454–462 (1935).

    Google Scholar 

  53. G. H. A. Clowes and M. E. Krahl, Report of the Dedication of the Lilly Research Laboratories, Indianapolis, 73–79 (1934).

  54. E. G. Lodeman, Bulletin 60, Cornell University Agricultural Experiment Station, New York, 292–293 (1893).

    Google Scholar 

  55. W. F. Cooper and W. H. Nuttall, Ann. Appl. Biol. 1, 273–279 (1915).

    Google Scholar 

  56. F. Tattersfield, C. T. Gimingham and H. M. Morris, Ann. Appl. Biol. 12, 218–262 (1925).

    Google Scholar 

  57. W. A. Westgate and R. N. Raynor, Bulletin 634, University of California Agricultural Experiment Station, Berkeley (1940).

    Google Scholar 

  58. A. Meyer, Ann. d'Hyg. 12 (5th series), 440–442 (1934).

    Google Scholar 

  59. F. Ashton and A. Crafts, Mode of Action of Herbicides, pp. 256–265, Wiley-Interscience, New York (1973).

    Google Scholar 

  60. H. Martin, The Scientific Principles of Crop Protection, 6th edition, pp. 178, 217, 270, Edward Arnold, London (1973).

    Google Scholar 

  61. P. L. Bidstrup, Brit. Med. J. 2, 16–19 (1951)

    Google Scholar 

  62. M. E. Krahl and G. H. A. Clowes, J. Gen. Physiol. 23, 413–427 (1940).

    Google Scholar 

  63. H. Lardy and P. Phillips, J. Biol. Chem. 149, 177–182, (the quotation is from p. 182) (1943).

    Google Scholar 

  64. H. Lardy and C. A. Elvehjem, Ann. Rev. Biochem. 14, 1–30 (1945).

    Google Scholar 

  65. F. Bernheim, The Interaction of Drugs and Cell Catalysis, revised edition, p. 54, Burgess, Minneapolis (1945).

    Google Scholar 

  66. F. Lipmann, Wanderings of a Biochemist, pp. 47–48, Wiley-Interscience, New York (1971).

    Google Scholar 

  67. F. Lipmann, Adv. Enzymology 1, 99–162 (1941).

    Google Scholar 

  68. W. F. Loomis and F. Lipmann, J. Biol. Chem. 173, 807–808 (1948).

    Google Scholar 

  69. F. Hoch, Energy Transformation in Mammals: Regulatory Mechanisms, pp. 53–54, 138–144, Saunders, Philadelphia (Physiological Chemistry, vol. 3) (1971).

    Google Scholar 

  70. A. Szent-Gyöorgi, Bioenergetics, p. 42, Academic Press, New York (1957).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parascandola, J. Dinitrophenol and bioenergetics: An historical perspective. Mol Cell Biochem 5, 69–77 (1974). https://doi.org/10.1007/BF01874175

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01874175

Keywords

Navigation